Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-19-000737
Filing Date
2019-05-08
Accepted
2019-05-08 20:09:32
Documents
2
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6810
2 poamayer.htm EX-24 7585
  Complete submission text file 0001123292-19-000737.txt   15770
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXTCURE, INC. 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address
Mayer Timothy (Reporting) CIK: 0001775460 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 19808418